T-Type Calcium Channels Are Required to Maintain Viability of Neural Progenitor Cells
Ji-Woon Kim1, Hyun Ah Oh1, Sung Hoon Lee2
1Department of Pharmacology and Department of Advanced Translational Medicine, School of Medicine, Konkuk University, Seoul 05029, Republic of Korea.
Abstract:
T-type calcium channels are low voltage-activated calcium channels that evoke small and transient calcium currents. Recently, T-type calcium channels have been implicated in neurodevelopmental disorders such as autism spectrum disorder and neural tube defects. However, their function during embryonic development is largely unknown. Here, we investigated the function and expression of T-type calcium channels in embryonic neural progenitor cells (NPCs). First, we compared the expression of T-type calcium channel subtypes (CaV3.1, 3.2, and 3.3) in NPCs and differentiated neural cells (neurons and astrocytes). We detected all subtypes in neurons but not in astrocytes. In NPCs, CaV3.1 was the dominant subtype, whereas CaV3.2 was weakly expressed, and CaV3.3 was not detected. Next, we determined CaV3.1 expression levels in the cortex during early brain development. Expression levels of CaV3.1 in the embryonic period were transiently decreased during the perinatal period and increased at postnatal day 11. We then pharmacologically blocked T-type calcium channels to determine the effects in neuronal cells. The blockade of T-type calcium channels reduced cell viability, and induced apoptotic cell death in NPCs but not in differentiated astrocytes. Furthermore, blocking T-type calcium channels rapidly reduced AKT-phosphorylation (Ser473) and GSK3β-phosphorylation (Ser9). Our results suggest that T-type calcium channels play essential roles in maintaining NPC viability, and T-type calcium channel blockers are toxic to embryonic neural cells, and may potentially be responsible for neurodevelopmental disorders.
Insights
T-type calcium channels are crucial for embryonic neural progenitor cell viability. Blocking these channels harms neural cells and may contribute to neurodevelopmental disorders like autism.
Area of Science:
- Neuroscience
- Developmental Biology
- Cell Biology
Background:
- T-type calcium channels (low voltage-activated) are implicated in neurodevelopmental disorders.
- Their specific role in embryonic neural progenitor cells remains largely unknown.
Purpose of the Study:
- To investigate the function and expression of T-type calcium channels in embryonic neural progenitor cells (NPCs).
- To determine the impact of T-type calcium channel blockade on NPC viability and signaling pathways.
Main Methods:
- Compared expression of CaV3.1, CaV3.2, and CaV3.3 subtypes in NPCs, neurons, and astrocytes.
- Analyzed CaV3.1 expression during embryonic and postnatal cortical development.
- Pharmacologically blocked T-type calcium channels in NPCs and assessed cell viability, apoptosis, and key signaling pathway phosphorylation (AKT, GSK3β).
Main Results:
- CaV3.1 was the dominant T-type calcium channel subtype in NPCs, with CaV3.2 weakly expressed and CaV3.3 undetected.
- CaV3.1 expression showed transient decrease during the perinatal period.
- T-type calcium channel blockade reduced NPC viability, induced apoptosis, and decreased AKT and GSK3β phosphorylation.
Conclusions:
- T-type calcium channels are essential for maintaining embryonic neural progenitor cell viability.
- T-type calcium channel blockers exhibit toxicity towards embryonic neural cells.
- These findings suggest a potential link between T-type calcium channel activity and neurodevelopmental disorders.
Related Concept Videos
Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Antihypertensive Drugs: Action of Calcium Channel Blockers
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Ion Channels
Ion channels are specialized integral membrane proteins on the plasma membrane that allow...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Requirements for Human Life
Oxygen
Atmospheric air is only about 20 percent oxygen, but that oxygen is a key component of the chemical reactions that keep the body alive, including the reactions that produce ATP. Brain cells are susceptible to a lack of oxygen because they require a...


